Journal of Food Science and Biotechnology
Abstract
[Objective ] This study aims to compare the effects of hesperetin and eriocitrin on the gut microbiota in different enterotypes.[Method ] An in vitro gut fermentation model was established,which was combined with 16S rRNA high-throughput sequencing and gas chromatography-mass spectrometry (GC-MS ) technique to evaluate the regulatory effects of the two flavonoids on the gut microbiota in different enterotypes.[Result ] After fermentation,both flavonoids significantly reduced the Firmicutes-to-Bacteroidota ratio (F/B ratio ) in terms of relative abundance at the phylum level in enterotype Bacteroides and enterotype Prevotella.At the genus level,pro-inflammatory bacteria including Paeniclostridium and Sutterella showed decreased relative abundance in treatment groups.LEfSe analysis result identified that both hesperetin and eriocitrin increased the proportions of beneficial genera such as Lactobacillus and Lachnospiraceae _ND 3007 _group in the enterotype Bacteroides.The quantification results of short-chain fatty acids indicated significant increases in acetate and butyrate production in hesperetin-treated enterotype Bacteroides,while eriocitrin treatment showed no significant alterations.Spearman correlation analysis result revealed a significant positive correlation between the relative abundance of Lachnoclostridium and the butyrate production in the hesperetin-treated enterotype Bacteroides.[Conclusion ] Hesperetin significantly enriched beneficial bacteria and enhanced the production of short-chain fatty acids in enterotype Bacteroides.The results can provide a theoretical foundation for the flavonoid-mediated regulation of the gut ecosystem.
Publication Date
10-15-2025
First Page
132
Last Page
142
DOI
10.12441/spyswjs.20250703002
Recommended Citation
CHENG, Zeren; MENG, Xia; TANG, Kejing; SHEN, Ling; GU, Qing; and LI, Ping
(2025)
"Regulatory Effects of Hesperetin and Eriocitrin on Gut Microbiota in an in Vitro Simulation Model,"
Journal of Food Science and Biotechnology: Vol. 44:
Iss.
10, Article 14.
DOI: 10.12441/spyswjs.20250703002
Available at:
https://spsw.spyswjs.cnjournals.com/journal/vol44/iss10/14
References
［1］ KUMAR M，DAHIYA V，KASALA E R，et al.The renoprotective activity of hesperetin in cisplatin induced nephrotoxicity in rats：molecular and biochemical evidence［J］.Biomedicine & Pharmacotherapy，2017，89：1207 -1215.
［2］ LI L Y，FENG X，CHEN Y T，et al.A comprehensive study of eriocitrin metabolism in vivo and in vitro based on an efficient UHPLC-Q-TOF-MS/MS strategy ［J］.RSC Advances，2019，9（43）：24963 -24980.
［3］ MIYAKE Y，YAMAMOTO K，OSAWA T.Metabolism of antioxidant in lemon fruit （Citrus limon Bur m.f.） by human intestinal bacteria ［J］.Journal of Agricultural and Food Chemistry，1997，45（10）：3738 -3742.
［4］ GARG A，GARG S，ZANEVELD L J D，et al.Chemistry and pharmacology of the Citrus bioflavonoid hesperidin［J］.Phytotherapy Research，2001，15（8）：655-669.
［5］ PANCHE A N，DIWAN A D，CHANDRA S R.Flavonoids：an overview ［J］.Journal of Nutritional Science，2016，5：e47.
［6］ SANTOS E L，MAIA B H L N S，FERRIANI A P，et al.Flavonoids：classification，biosynthesis and chemical ecology［M］//JUSTINO G C.Flavonoids：from biosynthesis to human health.London：IntechOpen，2017.
［7］ 覃小丽，孙慧园，杨武，等.UPLC -ESI-Q-TOF -MS/MS分析槲皮苷在大鼠肠道菌群中的代谢 ［J］.中国中药杂志，2017，42（2）：357-362.QIN X L，SUN H Y，YANG W，et al.Analysis of metabolites of quercitrin in rat intestinal flora by using UPLC-ESI-Q-TOF-MS/MS ［J］.China Journal of Chinese Materia Medica，2017，42（2）：357-362.
［8］ FERREIRA P S，MANTHEY J A，NERY M S，et al.Pharmacokinetics and biodistribution of eriocitrin in rats［J］.Journal of Agricultural and Food Chemistry，2021，69（6）：1796 -1805.
［9］ YAO L L，LIU W，BASHIR M，et al.Eriocitrin：a review of pharmacological effects ［J］.Biomedicine & Pharmacotherapy，2022，154：113563.
［10］ SALEHI B，CRUZ-MARTINS N，BUTNARIU M，et al.Hespereti n’s health potential：moving from preclinical to clinical evidence and bioavailability issues，to upcoming strategies to overcome current limitations ［J］.Critical Reviews in Food Science and Nutrition，2022，62（16）：4449 -4464.
［11］ SEKIROV I，RUSSELL S L，ANTUNES L C M，et al.Gut microbiota in health and disease ［J］.Physiological Reviews，2010，90（3）：859-904.
［12］ RINNINELLA E，RAOUL P，CINTONI M，et al.What is the healthy gut microbiota composition ？A changing ecosystem across age，environment，diet，and diseases ［J］.Microorganisms，2019，7（1）：14.
［13］ ARUMUGAM M，RAES J，PELLETIER E，et al.Enterotypes of the human gut microbiome ［J］.Nature，2011，473（7346）：174-180.
［14］ 魏茹楠，毕云娇，沈思佳，等.肠型的起源、争议及临床应 用 的 研 究 进 展 ［J］.中 国 微 生 态 学 杂 志，2024，36（11）：1336 -1339.WEI R u’nan，BI Y J，SHEN S J，et al.The origin，controversy and clinical application of enterotypes：research progress ［J］.Chinese Journal of Microecology，2024，36（11）：1336 -1339.（in Chinese ）
［15］ WU C，YANG F M，ZHONG H Z，et al.Obesity-enriched gut microbe degrades myo-inositol and promotes lipid absorption ［J］.Cell Host & Microbe，2024，32（8）：1301 -1314.e9.
［16］ WU X G，ZHANG T，ZHANG T S，et al.The impact of gut microbiome enterotypes on ulcerative colitis：identifying key bacterial species and revealing species co-occurrence networks using machine learning ［J］.Gut Microbes，2024，16（1）：2292254.
［17］ LIU G S，SONG Y，YAN J S，et al.Identification of enterotype for patients with Alzheimer ’s disease ［J］.Journal of Translational Medicine，2025，23（1）：299.
［18］ WU Y F，GUO Y L，HUANG T R，et al.Licorice flavonoid alleviates gastric ulcers by producing changes in gut microbiota and promoting mucus cell regeneration ［J］.Biomedicine & Pharmacotherapy，2023，169：115868.
［19］ FENG R B，WANG Q，YU T T，et al.Quercetin ameliorates bone loss in OVX rats by modulating the intestinal flora-SCFAs-inflammatory signaling axis［J］.International Immunopharmacology，2024，136：112341.
［20］ 杨夕缘，杨波，赵建新，等.动物双歧杆菌乳亚种对便秘的改善研究 ［J］.食品与生物技术学报，2024，43（7）：22-34.YANG X Y，YANG B，ZHAO J X，et al.Exploration of the effect of Bifidobacterium animalis subsp.lactis on improving constipation ［J］.Journal of Food Science and Biotechnology，2024，43（7）：22-34.（in Chinese ）
［21］ KOH A，DE VADDER F，KOVATCHEVA-DATCHARY P，et al.From dietary fiber to host physiology：short-chain fatty acids as key bacterial metabolites ［J］.Cell，2016，165（6）：1332 -1345.
［22］ 顾敏雯，刘皓文，祝晨昕，等.益生菌对食源性脂质代谢紊乱相关疾病的缓解作用及机制研究进展 ［J］.食品与生物技术学报，2024，43（10）：21-31.GU M W，LIU H W，ZHU C X，et al.Research progress on the alleviating effects and mechanisms of probiotics on diet-induced lipid metabolism disorders ［J］.Journal of Food Science and Biotechnology，2024，43（10）：21-31.（in Chinese ）
［23］ PAN L X，YE H Y，PI X E，et al.Effects of several flavonoids on human gut microbiota and its metabolism by in vitro simulated fermentation ［J］.Frontiers in Microbiology，2023，14：1092729.
［24］ ZHAO Z L，LIU W，PI X E.In vitro effects of stachyose on the human gut microbiota ［J］.Starch，2021，73（7/8）：2100029.
［25］ COSTEA P I，HILDEBRAND F，ARUMUGAM M，et al.Enterotypes in the landscape of gut microbial community composition ［J］.Nature Microbiology，2018，3（1）：8-16.
［26］ 杨柳，欧仕益，黄俊卿，等.玉米皮阿魏酰低聚糖调节小鼠肠道菌群及缓解结肠炎的研究 ［J］.食品与生物技术学报，2024，43（5）：146-155.YANG L，OU S Y，HUANG J Q，et al.Regulation of colon microbiota and alleviation of colon colitis in mice by maize feruloylated oligosaccharides ［J］.Journal of Food Science and Biotechnology，2024，43（5）：146-155.（in Chinese ）
［27］ STOJANOV S，BERLEC A，ŠTRUKELJ B.The influence of probiotics on the Firmicutes/Bacteroidetes ratio in the treatment of obesity and inflammatory bowel disease［J］.Microorganisms，2020，8（11）：1715.
［28］ SANTOS BRAZ V，MELCHIOR K，MOREIRA C G.Escherichia coli as a multifaceted pathogenic and versatile bacterium ［J］.Frontiers in Cellular and Infection Microbiology，2020，10：548492.
［29］ DU W Q，LIU L X，MA Y，et al.Analysis of the gut microbiome in obese native Tibetan children living at different altitudes：a case-control study ［J］.Frontiers in Public Health，2022，10：963202.
［30］ SONG E J，HAN K，LIM T J，et al.Effect of probiotics on obesity-related markers per enterotype：a double-blind，placebo-controlled，randomized clinical trial ［J］.EPMA Journal，2020，11（1）：31-51.
［31］ WANG Y，NAN X M，ZHAO Y G，et al.Discrepancies among healthy，subclinical mastitic，and clinical mastitic cows in fecal microbiome and metabolome and serum metabolome ［J］.Journal of Dairy Science，2022，105（9）：7668 -7688.
［32］ WILLIAMS B L，HORNIG M，PAREKH T，et al.Application of novel PCR-based methods for detection，quantitation，and phylogenetic characterization of Sutterella species in intestinal biopsy samples from children with autism and gastrointestinal disturbances ［J］.mBio，2012，3（1）：e00261 -11.
［33］ 吴世英，魏方通，陈子琪，等.益生菌辅助治疗幽门螺杆菌感染的研究进展 ［J］.食品与生物技术学报，2025，44（4）：1-8.WU S Y，WEI F T，CHEN Z Q，et al.Research progress of probiotics in the adjuvant therapy of Helicobacter pylori infections ［J］.Journal of Food Science and Biotechnology，2025，44（4）：1-8.（in Chinese ）
［34］ NISHIWAKI H，HAMAGUCHI T，ITO M，et al.Short-chain fatty acid-producing gut microbiota is decreased in Parkinso n’s disease but not in rapid-eye-movement sleep behavior disorder ［J］.mSystems，2020，5（6）：e00797 -20.
［35］ 张倩.肠道菌群组成及乙酸在支气管肺发育不良中的作用研究 ［D］.重庆：重庆医科大学，2021.
［36］ VALDES D S，SO D，GILL P A，et al.Effect of dietary acetic acid supplementation on plasma glucose，lipid profiles，and body mass index in human adults：a systematic review and meta-analysis ［J］.Journal of the Academy of Nutrition and Dietetics，2021，121（5）：895-914.
［37］ AL-LAHHAM S H，PEPPELENBOSCH M P，ROELOFSEN H，et al.Biological effects of propionic acid in humans；metabolism，potential applications and underlying mechanisms ［J］.Biochimica et Biophysica Acta （BBA）-Molecular and Cell Biology of Lipids，2010，1801（11）：1175 -1183.
［38］ LEONEL A J，ALVAREZ-LEITE J I.Butyrate：implications for intestinal function ［J］.Current Opinion in Clinical Nutrition and Metabolic Care，2012，15（5）：474-479.